<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
63083-9254-1
</NDCCode>
<PackageDescription>
29.5 mL in 1 BOTTLE, DROPPER (63083-9254-1)
</PackageDescription>
<NDC11Code>
63083-9254-01
</NDC11Code>
<ProductNDC>
63083-9254
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Creosote Combination
</ProprietaryName>
<ProprietaryNameSuffix>
9254
</ProprietaryNameSuffix>
<NonProprietaryName>
Creosote Combination
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
19840815
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED HOMEOPATHIC
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Professional Complementary Health Formulas
</LabelerName>
<SubstanceName>
ACONITUM NAPELLUS WHOLE; AMARYLLIS BELLADONNA WHOLE; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYOSCYAMUS NIGER; IPECAC; LOBARIA PULMONARIA; LOBELIA INFLATA WHOLE; PHOSPHORUS; SILICON DIOXIDE; WOOD CREOSOTE
</SubstanceName>
<StrengthNumber>
4; 4; 6; 4; 30; 30; 4; 4; 4; 4; 5; 6; 6
</StrengthNumber>
<StrengthUnit>
[hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL
</StrengthUnit>
<Pharm_Classes>
Actively Acquired Immunity [PE], Inactivated Clostridium Tetani Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-01-09
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
19850815
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>